BOLT Earnings Date & History
Bolt Biotherapeutics Inc (NASDAQ NMS - GLOBAL MARKET) earnings schedule, consensus estimates and reported results for the last eight quarters.
Last updated Aug 19, 2026 at 7:34 PM ET
Bolt Biotherapeutics Inc
Biotechnology
- Next earnings date
- Tuesday, November 10, 2026
- Reporting session
- Time TBD
- EPS estimate
- $-3.26
- Revenue estimate
- $510,000
BOLT earnings history
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| Tuesday, May 12, 2026 | Q1 2026 | $-2.91 | $-4.31 | -48.3% | $26,000 |
| Thursday, March 12, 2026 | Q4 2025 | $-6.23 | $-3.84 | +38.4% | $2.5M |
| Wednesday, November 12, 2025 | Q3 2025 | $-5.90 | $-3.72 | +37.0% | $2.2M |
| Thursday, August 14, 2025 | Q2 2025 | $-6.58 | $-4.46 | +32.2% | $1.8M |
What the market is watching in BOLT's next report
- The full Earnings Read for this company: focus areas, peer read-through and prior-reaction context.
- Ticker Read combines trend, relative strength and catalysts in one research view.
- Scanners, Impact Radar and the members-only Weekly Watchlist are included.
Get the week's earnings by email
One free email each week: the reports that matter, when they land, and what the market is watching.
Frequently asked questions
- When is the next BOLT earnings date?
- Bolt Biotherapeutics Inc is scheduled to report on Tuesday, November 10, 2026 (Time TBD). Dates can change until the company confirms them.
- Does BOLT report before or after the market?
- The next report is scheduled time tbd.
- What EPS is expected for BOLT?
- Consensus EPS for the upcoming quarter is $-3.26, on revenue of $510,000.
Calendar data is provided for educational and research purposes only and is not investment advice. Release dates, times, estimates and results can change; always verify against the issuing company or agency.
BOLT earnings discussion
Anyone can read. Any free Hyper Stocks account can join in.
Create a free account to join the discussion. Reading is open to everyone — commenting is free, no subscription needed.
Loading discussion…
Member comments are opinions from individual users, not Hyper Stocks research, and are never personalised investment advice.